학술논문

Plasma fractalkine contributes to systemic myeloid diversity and PD‐L1/PD‐1 blockade in lung cancer.
Document Type
Article
Source
EMBO Reports; 8/3/2023, Vol. 24 Issue 8, p1-16, 16p
Subject
Language
ISSN
1469221X
Abstract
Copyright of EMBO Reports is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)